ResoTher Pharma A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About ResoTher Pharma A/S
ResoTher Pharma A/S (CVR number: 37852406) is a company from RUDERSDAL. The company recorded a gross profit of -815.4 kDKK in 2017. The operating profit was -1026.2 kDKK, while net earnings were -832.1 kDKK. The profitability of the company measured by Return on Assets (ROA) was -86.3 %, which can be considered poor and Return on Equity (ROE) was -86.9 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 80.6 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. ResoTher Pharma A/S's liquidity measured by quick ratio was 5.1 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2017 | |
---|---|
Volume | |
Net sales | |
Gross profit | - 815.36 |
EBIT | -1 026.17 |
Net earnings | - 832.13 |
Shareholders equity total | 957.83 |
Balance sheet total (assets) | 1 189.09 |
Net debt | - 874.53 |
Profitability | |
EBIT-% | |
ROA | -86.3 % |
ROE | -86.9 % |
ROI | -107.1 % |
Economic value added (EVA) | - 832.12 |
Solvency | |
Equity ratio | 80.6 % |
Gearing | |
Relative net indebtedness % | |
Liquidity | |
Quick ratio | 5.1 |
Current ratio | 5.1 |
Cash and cash equivalents | 874.53 |
Capital use efficiency | |
Trade debtors turnover (days) | |
Net working capital % | |
Credit risk | |
Credit rating | BB |
Variable visualization
Roles
Companies in the same industry
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.